Showing 2 posts of 2 posts found.
Shire has announced its fiscal results for Q2 2016, reporting a strong quarter with a 56% growth in total revenues …
Eli Lilly has released its financial report for the second quarter of 2016, noting a number of promising results. The …
NHS England approves delayed-release treatment for rare kidney disease
Product value to pathway impact: What the CVD Modern Service Framework means for pharma
Functional lung imaging offers new possibilities for respiratory care
Five Facts about cardiovascular disease
Data integrity: the keystone for AI adoption, patient safety and organisational reputation